$BGXX
Bright Green Corp Stock $bgxx

$bgxx Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223012561 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.827M	$1.452M	$26.61M
YoY Change	-77.72%	98.35%	1430.39%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$159.2K	$177.9K	$704.7K
YoY Change	-18.21%	-6.1%	-6.26%
% of Gross Profit
Operating Expenses	$2.987M	$1.629M	$27.31M
YoY Change	-76.82%	76.87%	996.72%
Operating Profit	-$2.987M		-$27.31M
YoY Change	-76.82%		996.72%
Interest Expense	-$720.00	-$213.0K	-$213.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$724.00		$213.0K
YoY Change
Pretax Income	-$2.987M	-$1.842M	-$27.53M
YoY Change	-76.81%	99.99%	1005.28%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$2.992M	-$1.978M	-$27.66M
YoY Change	-76.77%	114.66%	1010.7%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02		-$0.17
Diluted Earnings Per Share	-$0.02	-$0.01	-$0.17
COMMON SHARES
Basic Shares Outstanding	174.4M shares	169.3M shares	162.1M shares
Diluted Shares Outstanding	176.2M shares		162.1M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$507.4K	$414.6K	$414.6K
YoY Change	183.54%	-67.68%	-67.68%
Cash & Equivalents	$507.4K	$414.6K
Short-Term Investments
Other Short-Term Assets	$182.1K	$77.85K	$77.85K
YoY Change	72.58%	-53.72%	-53.72%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$689.6K	$492.4K	$492.4K
YoY Change	142.38%	-66.06%	-66.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$19.10M	$17.15M	$17.15M
YoY Change	99.87%	133.96%	133.96%
Goodwill
YoY Change
Intangibles	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Long-Term Investments	$3.986M	$135.2K	$3.991M
YoY Change
Other Assets	$1.110M	$1.158M	$1.158M
YoY Change
Total Long-Term Assets	$24.20M	$22.30M	$22.30M
YoY Change	153.17%	204.18%	204.18%
TOTAL ASSETS
Total Short-Term Assets	$689.6K	$492.4K	$492.4K
Total Long-Term Assets	$24.20M	$22.30M	$22.30M
Total Assets	$24.89M	$22.79M	$22.79M
YoY Change	152.86%	159.53%	159.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.409M	$5.034M	$5.034M
YoY Change	285.53%	3257.34%	3257.23%
Accrued Expenses	$945.9K	$447.3K	$447.3K
YoY Change	838.03%	2381.42%	2381.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.004M	$7.523M	$7.523M
YoY Change	322.19%	4379.2%	4379.25%
LONG-TERM LIABILITIES
Long-Term Debt	$3.562M	$3.686M	$3.686M
YoY Change
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$3.562M	$3.686M	$3.686M
YoY Change	77.66%	839.87%	839.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.004M	$7.523M	$7.523M
Total Long-Term Liabilities	$3.562M	$3.686M	$3.686M
Total Liabilities	$11.57M	$11.21M	$11.21M
YoY Change	196.51%	1901.13%	1901.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.68M	-$34.08M
YoY Change	98.18%	431.29%
Common Stock	$53.00M	$45.65M
YoY Change	104.13%	211.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.32M	$11.58M	$11.58M
YoY Change
Total Liabilities & Shareholders Equity	$24.89M	$22.79M	$22.79M
YoY Change	152.86%	159.53%	159.53%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.992M	-$1.978M	-$27.66M
YoY Change	-76.77%	114.66%	1010.7%
Depreciation, Depletion And Amortization	$159.2K	$177.9K	$704.7K
YoY Change	-18.21%	-6.1%	-6.26%
Cash From Operating Activities	-$2.352M	$2.078M	-$2.266M
YoY Change	-36.03%	-429.31%	36.77%
INVESTING ACTIVITIES
Capital Expenditures	$685.5K	$4.907M	$10.52M
YoY Change	-138.25%	-1720.92%	-3575.9%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$2.419M	-$3.847M
YoY Change
Cash From Investing Activities	-$685.5K	-$7.326M	-$14.37M
YoY Change	-61.75%	2319.92%	4646.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$3.050M
YoY Change			-2.56%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.123M	1.600M	$15.77M
YoY Change	-37.55%	88.05%	402.19%
NET CHANGE
Cash From Operating Activities	-2.352M	2.078M	-$2.266M
Cash From Investing Activities	-685.5K	-7.326M	-$14.37M
Cash From Financing Activities	3.123M	1.600M	$15.77M
Net Change In Cash	84.94K	-3.648M	-$868.0K
YoY Change	-118.1%	4304.58%	-173.54%
FREE CASH FLOW
Cash From Operating Activities	-$2.352M	$2.078M	-$2.266M
Capital Expenditures	$685.5K	$4.907M	$10.52M
Free Cash Flow	-$3.038M	-$2.829M	-$12.79M
YoY Change	61.14%	762.02%	844.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001886799
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments		usd
CY2021Q4	BGXX	Due To Others Current DueToOthersCurrent		usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		usd
CY2022Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent		usd
CY2021Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit		usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2021	BGXX	Change In Fair Value Of Voting Agreement Derivative ChangeInFairValueOfVotingAgreementDerivative		usd
CY2021	us-gaap	Other Expenses OtherExpenses		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	BGXX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Equity In Net Losses Of Affiliate IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestEquityInNetLossesOfAffiliate		usd
CY2021	BGXX	Change In Fair Value Of Voting Agreement Derivative ChangeInFairValueOfVotingAgreementDerivative		usd
CY2021	BGXX	Equity In Net Losses Of Affiliate EquityInNetLossesOfAffiliate		usd
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		usd
CY2021	BGXX	Payments For Acquire Property Deposits PaymentsForAcquirePropertyDeposits		usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit		usd
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Transfer Of Investments TransferOfInvestments		usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure		usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross		usd
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41395
CY2022	dei	Entity Registrant Name EntityRegistrantName	BRIGHT GREEN CORPORATION
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-4600841
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1033 George Hanosh Boulevard
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Grants
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NM
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	87020
CY2022	dei	City Area Code CityAreaCode	(833)
CY2022	dei	Local Phone Number LocalPhoneNumber	658-1799
CY2022	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	BGXX
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	141818084	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	174423810	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11578836	usd
CY2022	dei	Auditor Location AuditorLocation	Amherst, NY
CY2022	dei	Auditor Name AuditorName	SRCO, C.P.A., Professional Corporation
CY2022	dei	Auditor Firm AuditorFirmId	6722
CY2022Q4	us-gaap	Cash Cash	414574	usd
CY2021Q4	us-gaap	Cash Cash	1282565	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77847	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	168226	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	492421	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1450791	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1157587	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3990960	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17146325	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7328764	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2022Q4	us-gaap	Assets Assets	22788293	usd
CY2021Q4	us-gaap	Assets Assets	8780555	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5033831	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	149935	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	447325	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18027	usd
CY2022Q4	BGXX	Due To Others Current DueToOthersCurrent	1650000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	392194	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7523350	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	167962	usd
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	392194	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	3686107	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3686107	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	392194	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11209457	usd
CY2021Q4	us-gaap	Liabilities Liabilities	560156	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173304800	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173304800	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	157544500	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157544500	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	17329	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	15754	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	45637328	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14618389	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34075821	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6413744	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8220399	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22788293	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8780555	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26609241	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1738716	usd
CY2022	us-gaap	Depreciation Depreciation	704681	usd
CY2021	us-gaap	Depreciation Depreciation	751783	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	27313922	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	2490499	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-27313922	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2490499	usd
CY2022	BGXX	Change In Fair Value Of Voting Agreement Derivative ChangeInFairValueOfVotingAgreementDerivative	213000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	213000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27526922	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2490499	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-27526922	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2490499	usd
CY2022	BGXX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Equity In Net Losses Of Affiliate IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestEquityInNetLossesOfAffiliate	-135155	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27662077	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2490499	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	162058082	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156800164	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	7220898	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	360000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3130000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2490499	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8220399	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8220399	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3050000	usd
CY2022	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	863267	usd
CY2022	BGXX	Common Stock And Warrants Issued Value For Cash In Private Placements CommonStockAndWarrantsIssuedValueForCashInPrivatePlacements	9136733	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	18851232	usd
CY2022	BGXX	Stock Cancelled During Period Value Issued For Services StockCancelledDuringPeriodValueIssuedForServices	-17451	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27662077	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11578836	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11578836	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27662077	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2490499	usd
CY2022	BGXX	Change In Fair Value Of Voting Agreement Derivative ChangeInFairValueOfVotingAgreementDerivative	213000	usd
CY2022	BGXX	Equity In Net Losses Of Affiliate EquityInNetLossesOfAffiliate	135155	usd
CY2022	us-gaap	Depreciation Depreciation	704681	usd
CY2021	us-gaap	Depreciation Depreciation	751783	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	18833781	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	360000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-90379	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	149153	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4883896	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-30403	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	429298	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-98303	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-106117	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2265770	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1656575	usd
CY2022	BGXX	Payments For Acquire Property Deposits PaymentsForAcquirePropertyDeposits	1157587	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2689115	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10522242	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	302717	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14368944	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-302717	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	122514	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	112920	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	5191057	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1611067	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3050000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3130000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9136733	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15766723	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3139594	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-867991	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1180302	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1282565	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	102263	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	414574	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1282565	usd
CY2022	us-gaap	Transfer Of Investments TransferOfInvestments	1650000	usd
CY2022	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-04-16
CY2022	us-gaap	Revenues Revenues	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27662077	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2490499	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2265770	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1656575	usd
CY2022Q4	BGXX	Working Capital WorkingCapital	-7030929	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34075821	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	12186733	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	5191057	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1611067	usd
CY2022Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	11300000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	213000	usd
CY2022	BGXX	Change In Fair Value Of Voting Agreement Derivative ChangeInFairValueOfVotingAgreementDerivative	213000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	78193	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	68571	usd
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination
CY2022	us-gaap	Revenues Revenues	0	usd
CY2021	us-gaap	Revenues Revenues	0	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zVonxPeM9Sfd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_z71weYIrXZAl">Use of Estimates</span></span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to valuation allowance for deferred tax assets, valuation of warrants and stock-based compensation, valuation of option related to equity investment, going concern assessment and assignment of the useful lives of property, plant and equipment. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p>
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	201761982	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3999999
CY2022Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	1650000	usd
CY2021Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	1000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	187821	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	807047948	shares
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.67	pure
CY2022Q4	BGXX	Enterprise Value Cash EnterpriseValueCash	50000000	usd
CY2022Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	339115	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	135155	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	88690	usd
CY2022Q4	us-gaap	Land Land	260000	usd
CY2021Q4	us-gaap	Land Land	260000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10736269	usd
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	302717	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8883851	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8883851	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19968810	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9446568	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2822485	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2117804	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17146325	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7328764	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	106117	usd
CY2022Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	1000	usd
CY2022	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	2219285	usd
CY2022	BGXX	Payments For Acquire Property Deposit PaymentsForAcquirePropertyDeposit	1109643	usd
CY2022	us-gaap	Payments For Deposits PaymentsForDeposits	1109642	usd
CY2022Q4	us-gaap	Construction Contract Cost Progress Payment Offset ConstructionContractCostProgressPaymentOffset	47944	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1611067	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	106117	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	106117	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173304800	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173304800	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	157544500	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157544500	shares
CY2022	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	800000	usd
CY2022	us-gaap	Legal Fees LegalFees	55617	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	7650	usd
CY2022Q4	us-gaap	Share Price SharePrice	1.65
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.05
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1.743	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0341	pure
CY2022	BGXX	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dilutive Issuance Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDilutiveIssuanceRate	0.15	pure
CY2022Q3	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	4489662	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.258	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.258	pure
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-27662077	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2490499	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5727839	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-515114	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1309220	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-117740	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7037059	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-632854	usd
CY2022	BGXX	Valuation Allowances Of Income Tax Expense Benefit ValuationAllowancesOfIncomeTaxExpenseBenefit	-7037059	usd
CY2021	BGXX	Valuation Allowances Of Income Tax Expense Benefit ValuationAllowancesOfIncomeTaxExpenseBenefit	-632854	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	728201	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	546393	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7294146	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	438894	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8022347	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	985287	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8022347	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	985287	usd
CY2022Q4	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	392194	usd
CY2021Q4	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	392194	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	3686107	usd
CY2022	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_801_eus-gaap--LossContingencyDisclosures_zouNs7vOoMai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15. </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_824_zxjuusupgt47">Contingencies</span> </span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company is routinely defendants in, or parties to a number of pending and threatened legal actions including actions brought on behalf of various classes of claimants. In view of the inherent difficulty of predicting the outcome of such matters, the Company cannot state what the eventual outcome of such matters will be. Legal provisions are established when it becomes probable that the Company will incur an expense related to a legal action and the amount can be reliably estimated. Such provisions are recorded at the best estimate of the amount required to settle any obligation related to these legal actions as at the balance sheet date, taking into account the risks and uncertainties surrounding the obligation. Management and internal and external experts are involved in estimating any amounts that may be required. The actual costs of resolving these claims may vary significantly from the amount of the legal provisions. The Company’s estimate involves significant judgement, given the varying stages of the proceedings, the fact that the Company’s liability, if any, has yet to be determined and the fact that the underlying matters will change from time to time. Other than as set forth below, the Company is not presently a party to any litigation. The Company is not able to make a reliable assessment of the potential losses as these matters are at an early stage, accordingly, no amounts have been accrued in the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15. </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contingencies (continued)</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bright Green Corporation v. John Fikany, State of New Mexico, County of Cibola, Thirteenth Judicial District</i>. In this matter, the Company filed a complaint for declaratory judgment against a consultant of the <span id="xdx_90B_eus-gaap--LossContingencyActionsTakenByDefendant_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zWXCBNTubT1k" title="Contingency, taken by defendant description">Bright Green Group of Companies, an entity unrelated to the Company, to determine if defendant is entitled to 5,000,000 shares of the Company’s common stock, based on a failure to fulfill agreed upon conditions precedent to earning such shares from the Company.</span> Defendant counterclaimed and filed a third-party claim against a director of the Company, and her spouse, for claims including wrongful termination and breach of contract. The Company denies defendants allegations and have set forth arguments refuting defendant’s counterclaims and third-party claims. The case is in the discovery phase. The Company is exploring potential dispositive motions against the counter and third-party claims.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bright Green Corporation v. Jerry Capussi, State of New Mexico, County of Cibola, Thirteenth Judicial District</i>. In this matter, the Company and defendant, a former consultant of Sunnyland Farms Inc., an entity unrelated to the Company, have each filed claims for declaratory judgment seeking to determine by court order whether defendant is entitled to <span id="xdx_90F_eus-gaap--LossContingencyActionsTakenByDefendant_c20220101__20221231_zSXgrYMdA14g" title="Contingency, taken by defendant description">(i) shares of common stock in the Company (amounting to no more than 108,000 shares) or (ii) fair market value of defendant’s equity ownership of BGGI</span>. The lawsuit is in early discovery stages, and the Company is preparing arguments for a summary judgment motion. There are no claims for specific monetary liability against either party.</span></p>
CY2022	us-gaap	Loss Contingency Actions Taken By Defendant LossContingencyActionsTakenByDefendant	(i) shares of common stock in the Company (amounting to no more than 108,000 shares) or (ii) fair market value of defendant’s equity ownership of BGGI

Files In Submission

Name	View Source	Status
bgxx-20221231_cal.xml	Edgar Link	unprocessable
0001493152-23-012561-index-headers.html	Edgar Link	pending
0001493152-23-012561-index.html	Edgar Link	pending
0001493152-23-012561.txt	Edgar Link	pending
0001493152-23-012561-xbrl.zip	Edgar Link	pending
audit_001.jpg	Edgar Link	pending
bgxx-20221231.xsd	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
bgxx-20221231_def.xml	Edgar Link	unprocessable
bgxx-20221231_lab.xml	Edgar Link	unprocessable
bgxx-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BGXX
Bright Green Corp Stock $bgxx

2023 Q2 Form 10-K Financial Statement

#000149315223012561 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGXX Bright Green Corp Stock $bgxx

2023 Q2 Form 10-K Financial Statement

#000149315223012561 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGXX
Bright Green Corp Stock $bgxx